Protective Vaccine-Induced CD4+T Cell-Independent B Cell Responses against Rabies Infection
- 1 November 2012
- journal article
- Published by American Society for Microbiology in Journal of Virology
- Vol. 86 (21), 11533-11540
- https://doi.org/10.1128/jvi.00615-12
Abstract
A major goal in rabies virus (RV) research is to develop a single-dose postexposure prophylaxis (PEP) that would simplify vaccination protocols, reduce costs associated with rabies prevention in humans, and save lives. Live replication-deficient RV-based vaccines are emerging as promising single-dose vaccines to replace currently licensed inactivated RV-based vaccines. Nonetheless, little is known about how effective B cells develop in response to live RV-based vaccination. Understanding this fundamental property of rabies immunology may help in developing a single-dose RV vaccine. Typically, vaccines induce B cells secreting high-affinity, class-switched antibodies during germinal center (GC) reactions; however, there is a lag time between vaccination and the generation of GC B cells. In this report, we show that RV-specific antibodies are detected in mice immunized with live but not inactivated RV-based vaccines before B cells displaying a GC B cell phenotype (B220(+)GL7(hi)CD95(hi)) are formed, indicating a potential role for T cell-independent and early extrafollicular T cell-dependent antibody responses in the protection against RV infection. Using two mouse models of CD4(+) T cell deficiency, we show that B cells secreting virus-neutralizing antibodies (VNAs) are induced via T cell-independent mechanisms within 4 days postimmunization with a replication-deficient RV-based vaccine. Importantly, mice that are completely devoid of T cells (B6.129P2-Tcrβ(tm1Mom) Tcrδ(tm1Mom)/J) show protection against pathogenic challenge shortly after immunization with a live replication-deficient RV-based vaccine. We show that vaccines that can exploit early pathways of B cell activation and development may hold the key for the development of a single-dose RV vaccine wherein the rapid induction of VNA is critical.Keywords
This publication has 30 references indexed in Scilit:
- Experimental rabies vaccines for humansExpert Review of Vaccines, 2010
- Rabies Virus Infection Induces Type I Interferon Production in an IPS-1 Dependent Manner While Dendritic Cell Activation Relies on IFNAR SignalingPLoS Pathogens, 2010
- Rabies-Specific Antibodies: Measuring Surrogates of Protection against a Fatal DiseasePLoS Neglected Tropical Diseases, 2010
- IL-21 acts directly on B cells to regulate Bcl-6 expression and germinal center responsesThe Journal of Experimental Medicine, 2010
- Toll-Like Receptors and B-Cell Receptors Synergize to Induce Immunoglobulin Class-Switch DNA Recombination: Relevance to Microbial Antibody ResponsesCritical Reviews in Immunology, 2010
- Replication‐Deficient Rabies Virus–Based Vaccines Are Safe and Immunogenic in Mice and Nonhuman PrimatesThe Journal of Infectious Diseases, 2009
- Follicular helper T cells are required for systemic autoimmunityThe Journal of Experimental Medicine, 2009
- Immune modulating effect by a phosphoprotein-deleted rabies virus vaccine vector expressing two copies of the rabies virus glycoprotein geneVaccine, 2008
- Vaccines: Correlates of Vaccine‐Induced ImmunityClinical Infectious Diseases, 2008
- Rabies Virus Cross-Reactive Murine T Cell Clones: Analysis of Helper and Delayed-Type Hypersensitivity FunctionViral Immunology, 1990